Login / Signup
Plamen Zagorchev
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 8
Top Topics
Cancer Therapy
Papillary Thyroid
Iron Oxide Nanoparticles
Drug Release
Top Venues
Pharmaceutics
Journal of functional biomaterials
Medicina (Kaunas, Lithuania)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Desislava R Makakova
,
Plamen Zagorchev
,
Mariya Dimitrova
,
Yoanna Georgieva
,
Boris Tilov
Absorptive Capacity of Gingival Retraction Cords in Hemostatic Solutions: An In Vitro Study.
Medicina (Kaunas, Lithuania)
60 (8) (2024)
Tsenka Grancharova
,
Plamen Zagorchev
,
Bissera Pilicheva
Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.
Journal of functional biomaterials
15 (8) (2024)
Tsenka Grancharova
,
Plamen Zagorchev
,
Bissera Pilicheva
Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.
Journal of functional biomaterials
15 (8) (2024)
Tsenka Grancharova
,
Plamen Zagorchev
,
Bissera Pilicheva
Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.
Journal of functional biomaterials
15 (8) (2024)
Nikolay Zahariev
,
Milena Draganova
,
Plamen Zagorchev
,
Bissera Pilicheva
Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia.
Pharmaceutics
15 (2) (2023)
Nikolay Zahariev
,
Milena Draganova
,
Plamen Zagorchev
,
Bissera Pilicheva
Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia.
Pharmaceutics
15 (2) (2023)
Nikolay Zahariev
,
Milena Draganova
,
Plamen Zagorchev
,
Bissera Pilicheva
Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia.
Pharmaceutics
15 (2) (2023)
Nikolay Zahariev
,
Milena Draganova
,
Plamen Zagorchev
,
Bissera Pilicheva
Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia.
Pharmaceutics
15 (2) (2023)